Filing Details
- Accession Number:
- 0001179110-13-001019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-17 16:23:03
- Reporting Period:
- 2013-01-16
- Filing Date:
- 2013-01-17
- Accepted Time:
- 2013-01-17 16:23:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1277478 | Glenn Sblendorio | 8 Sylvan Way Parsippany NJ 07054 | President & Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-01-16 | 25,000 | $19.36 | 122,282 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-16 | 25,000 | $30.00 | 97,282 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-01-16 | 100,000 | $20.11 | 197,282 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-16 | 100,000 | $30.00 | 97,282 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Disposition | 2013-01-16 | 25,000 | $0.00 | 25,000 | $19.36 |
Common Stock | Common stock | Disposition | 2013-01-16 | 100,000 | $0.00 | 100,000 | $20.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,495 | 2018-02-15 | No | 4 | M | Direct | |
50,000 | 2016-03-03 | No | 4 | M | Direct |
Footnotes
- The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Sblendorio on February 18, 2011.
- As of 1/16/2013, the original grant (99,495 shares granted on 2/15/2008) was fully vested. After the exercise of the options reported hereby, as of 1/16/2013, the remaining 24,495 shares covered by this option are vested but not exercised.
- As of 1/16/2013, the original grant (150,000 shares granted on 3/3/2006) was fully vested. After the exercise of the options reported hereby, as of 1/16/2013, the remaining 50,000 shares covered by this option are vested but not exercised.